Lot Consistency
Showing 1 - 25 of 1,519
Hand, Foot and Mouth Disease Trial (EV71 Vaccine)
Not yet recruiting
- Hand, Foot and Mouth Disease
- EV71 Vaccine
- (no location specified)
Nov 17, 2023
Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine (lot 1), Investigational live attenuated varicella
Not yet recruiting
- Varicella
- Investigational live attenuated varicella vaccine (lot 1)
- +2 more
-
Xuzhou, Jiangsu, ChinaXinyi Center for Disease Control and Prevention
Apr 20, 2023
Pneumococcal Infections Trial in Yuanping, Yuncheng (Experimental 23-valent Pneumococcal)
Not yet recruiting
- Pneumococcal Infections
- Experimental 23-valent Pneumococcal
-
Yuanping, Shanxi, China
- +1 more
Feb 7, 2023
Seasonal Influenza Trial in Zhumadian (Quadrivalent Influenza Vaccine (Split Virion), inactivated)
Not yet recruiting
- Seasonal Influenza
- Quadrivalent Influenza Vaccine (Split Virion), inactivated
-
Zhumadian, Guizhou, ChinaYuping Dong Autonomous County Center for Disease Control and Pre
Aug 21, 2022
Pneumococcal Disease Trial in United States (V116, PPSV23)
Not yet recruiting
- Pneumococcal Disease
- V116
- PPSV23
- (no location specified)
Jul 12, 2022
Rabies, Prevention Trial (PIKA-adjuvanted inactivated rabies vaccine, Rabipur)
Not yet recruiting
- Rabies
- Prevention
- PIKA-adjuvanted inactivated rabies vaccine
- Rabipur
- (no location specified)
Dec 28, 2022
COVID-19 Trial in Huai'an (Inactivated SARS-CoV-2 Vaccine (Vero cell))
Completed
- COVID-19
- Inactivated SARS-CoV-2 Vaccine (Vero cell）
-
Huai'an, Jiangsu, ChinaJingliang Wu
Apr 12, 2022
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Cholera Trial in India (Hillchol vaccine, Shanchol Vaccine)
Active, not recruiting
- Cholera
- Hillchol vaccine
- Shanchol Vaccine
-
Visakhapatnam, Andhra Pradesh, India
- +10 more
Aug 17, 2022
COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel
Active, not recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
-
Yancheng, Jiangsu, ChinaFuning Center for Disease Control and Prevention
Oct 28, 2022
Poliomyelitis Trial in Kaifeng, Xuchang (Experimental vaccine, IPV control vaccine, single-person sIPV control vaccine)
Active, not recruiting
- Poliomyelitis
- Experimental vaccine
- +2 more
-
Kaifeng, Henan, China
- +1 more
May 24, 2022
Cholera Trial in Nepal (Oral Cholera Vaccine Simplified (OCV-S), Shanchol™)
Recruiting
- Cholera
- Oral Cholera Vaccine Simplified (OCV-S)
- Shanchol™
-
Banke, City- Nepalgunj, Nepal
- +3 more
Dec 2, 2021
COVID-19 Trial in Xi'an (Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2, Inactivated SARS-CoV-2 Vaccine
Active, not recruiting
- COVID-19
- Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
- +6 more
-
Xi'an, Shanxi, ChinaYaliang county Center for Disease Control and Prevention
Dec 13, 2021
Safety Issues, Immunogenicity Trial in Jakarta (Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi
Completed
- Safety Issues
- Immunogenicity
- Vi-DT Typhoid Conjugate Vaccine
- +2 more
-
Jakarta, Jakart, IndonesiaJatinegara Primary Health Care
Dec 30, 2021
Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human
Completed
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
-
Dongtai, Jiangsu, ChinaDongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022
COVID-19 Trial in Guelph, Toronto (CoVLP formulation)
Not yet recruiting
- COVID-19
- CoVLP formulation
-
Guelph, Ontario, Canada
- +1 more
Sep 8, 2021
Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile vaccine, )
Completed
- Clostridium Difficile Associated Disease
- Clostridium difficile vaccine
- placebo
-
Mobile, Alabama
- +23 more
Dec 21, 2022
Cholera Trial in India (Hillchol vaccine)
Recruiting
- Cholera
- Hillchol vaccine
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Feb 8, 2023
Poliomyelitis Trial in Honghe, Wenshan (Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age, Three
Completed
- Poliomyelitis
- Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age
- +3 more
-
Honghe, Yunnan, China
- +3 more
Aug 16, 2021
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine
Completed
- Respiratory Syncytial Virus Infections
- RSV MAT Lot 1 vaccine (GSK3888550A)
- +4 more
-
West Palm Beach, Florida
- +35 more
Jul 14, 2022
Rotavirus Gastroenteritis Trial in Surakarta, Yogyakarta (Rotavirus RV3 Vaccine (Bio Farma), Placebo)
Active, not recruiting
- Rotavirus Gastroenteritis
- Rotavirus RV3 Vaccine (Bio Farma)
- Placebo
-
Surakarta, Indonesia
- +20 more
Aug 26, 2022
Chikungunya Virus Infection Trial in United States (Biological Vaccine VLA1553)
Completed
- Chikungunya Virus Infection
- Biological Vaccine VLA1553
-
Coral Gables, Florida
- +11 more
Jan 31, 2022
Lyme Disease Trial in Worldwide (VLA15, Saline)
Not yet recruiting
- Lyme Disease
- VLA15
- Saline
-
New London, Connecticut
- +25 more
Aug 2, 2022
Influenza Trial (QIV-IB, TIVV-IB, TIVY-IB)
Not yet recruiting
- Influenza
- QIV-IB
- +5 more
- (no location specified)
Feb 2, 2021